Weldon Sloan handles complex commercial litigation and appeals, with an emphasis on oil and gas disputes. In his practice, Weldon frequently draws on his extensive experience as a judicial law clerk in state and federal courts. Before joining the firm, Weldon served as a law clerk for the Hon. Brett Busby of the Texas Supreme Court, the Hon. Rebecca Rutherford of the Northern District of Texas, and the Hon. E. Lee Morris of the Northern District of Texas Bankruptcy Court. During law school, Weldon served as an intern for the Hon. Mark Lane of the Western District of Texas and as a member of the Texas Law Review editorial board. Weldon has also published writings in legal journals on topics related to federal courts, the First Amendment, and bankruptcy.
Locations
Dallas
2200 Ross Ave. | Ste. 4200W
Dallas, TX 75201
Representative Experience
Upland Exploration, LLC v. Mewbourne Oil Company
Representing Mewbourne in two resolved lawsuits related to Upland’s leasing activities and Mewbourne’s drilling activities in the Cherokee Play of the Western Anadarko Basin in Oklahoma
Credentials
Admissions
- Texas
- Northern District of Texas
Clerkships/Judicial Internships
- Law clerk for the Hon. Brett Busby, Texas Supreme Court
- Law clerk for the Hon. E. Lee Morris, U.S. Bankruptcy Court for the Northern District of Texas
- Law clerk for the Hon. Rebecca Rutherford, U.S. District Court for the Northern District of Texas
- Judicial intern for the Hon. Mark Lane, U.S. District court for the Western District of Texas
Education
- University of Texas (J.D., 2021)
- With Honors
- Order of the Coif
- Texas Law Review, Editorial Board
- Hardin Simmons University (B.B.S., 2016)
- With high honors
Publications
- Co-Author, “Allocation Wells,” ALTA, November 6, 2025.
- Co-Author, “Production in Paying Quantities,” Dallas-Fort Worth Association of Lease and Title Analysts (DFW-ALTA) Fall Seminar, October 16, 2025.
- Co-author, Faith, Federal Courts, and Free Speech, 22 First Amend. L. Rev. (forthcoming 2024)
- Author, Bankruptcy’s Thalidomide, 100 Texas L. Rev. 999 (2022)